Effectiveness of Apremilast in Real Life in Patients with Psoriasis: A Longitudinal Study

• Main Authors: Giovanna Malara (Author), Cristina Politi (Author), Caterina Trifirò (Author), Chiara Verduci (Author), Graziella D'Arrigo (Author), Alessandra Testa (Author), Giovanni Tripepi (Author)
• Format: Book
• Published: Medical Journals Sweden, 2021-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Apremilast is an oral selective phosphodiesterase-4 inhibitor developed recently for psoriasis treatment. The aim of this study is to assess the real-life outcomes of use of apremilast in patients with psoriasis in everyday clinical practice. A total of 159 adult patients (90 males) with plaque psor...